Iterum Therapeutics PLC (ITRM)
1.77
+0.14
(+8.59%)
USD |
NASDAQ |
Nov 21, 16:00
1.85
+0.08
(+4.52%)
After-Hours: 07:56
Iterum Therapeutics Enterprise Value: 31.18M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 31.18M |
| November 20, 2024 | 28.86M |
| November 19, 2024 | 27.04M |
| November 18, 2024 | 25.39M |
| November 15, 2024 | 24.56M |
| November 14, 2024 | 24.39M |
| November 13, 2024 | 25.55M |
| November 12, 2024 | 26.38M |
| November 11, 2024 | 24.89M |
| November 08, 2024 | 25.05M |
| November 07, 2024 | 23.40M |
| November 06, 2024 | 22.08M |
| November 05, 2024 | 23.23M |
| November 04, 2024 | 23.73M |
| November 01, 2024 | 22.08M |
| October 31, 2024 | 23.23M |
| October 30, 2024 | 21.91M |
| October 29, 2024 | 25.88M |
| October 28, 2024 | 25.55M |
| October 25, 2024 | 33.00M |
| October 24, 2024 | 21.25M |
| October 23, 2024 | 20.42M |
| October 22, 2024 | 19.76M |
| October 21, 2024 | 20.42M |
| October 18, 2024 | 21.25M |
| Date | Value |
|---|---|
| October 17, 2024 | 19.92M |
| October 16, 2024 | 18.93M |
| October 15, 2024 | 18.76M |
| October 14, 2024 | 18.60M |
| October 11, 2024 | 17.27M |
| October 10, 2024 | 17.27M |
| October 09, 2024 | 16.94M |
| October 08, 2024 | 17.74M |
| October 07, 2024 | 18.07M |
| October 04, 2024 | 18.52M |
| October 03, 2024 | 18.37M |
| October 02, 2024 | 19.26M |
| October 01, 2024 | 19.43M |
| September 30, 2024 | 19.92M |
| September 27, 2024 | 19.34M |
| September 26, 2024 | 19.18M |
| September 25, 2024 | 19.59M |
| September 24, 2024 | 20.25M |
| September 23, 2024 | 19.43M |
| September 20, 2024 | 19.34M |
| September 19, 2024 | 19.92M |
| September 18, 2024 | 19.92M |
| September 17, 2024 | 20.09M |
| September 16, 2024 | 19.43M |
| September 13, 2024 | 19.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-25.88M
Minimum
Sep 23 2022
394.05M
Maximum
Feb 10 2021
39.89M
Average
21.91M
Median
Jun 25 2024
Enterprise Value Benchmarks
| Alkermes PLC | 3.862B |
| Jazz Pharmaceuticals PLC | 11.06B |
| Medtronic PLC | 129.24B |
| Perrigo Co PLC | 6.985B |
| Mallinckrodt PLC | 1.332B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.101M |
| Total Expenses (Quarterly) | 6.163M |
| EPS Diluted (Quarterly) | -0.46 |
| Earnings Yield | -149.7% |
| Normalized Earnings Yield | -5610.17 |